Highstreet Asset Management’s Core Laboratories CLB Stock Holding History

Highstreet Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,714	Closed	-$530K	–	141
2016 Q1	$530K	Sell	4,714 -363	-7%	-$37.7K	0.19%	107
2015 Q4	$552K	Buy	5,077 +1,380	+37%	+$158K	0.12%	150
2015 Q3	$369K	Buy	+3,697	New	+$402K	0.12%	121

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Highstreet Asset Management's CLB Position: Q2 2016 in Review

Highstreet Asset Management sold out of Core Laboratories (CLB) in Q2 2016, closing a stake of 4,714 shares — an estimated $530K sold.

Highstreet Asset Management first reported a position in CLB in Q3 2015 and held it in 3 quarters. The position peaked at $552K in Q4 2015. 383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

Highstreet Asset Management reported no remaining Core Laboratories position as of Q2 2016 after selling out during the quarter.
Highstreet Asset Management sold 4,714 Core Laboratories shares in Q2 2016, an estimated $530K.
Highstreet Asset Management first reported a position in Core Laboratories in Q3 2015 and held it in 3 quarters.
Highstreet Asset Management's Core Laboratories position peaked at $552K in Q4 2015.
383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Highstreet Asset Management's 13F filing for Q2 2016, filed 22 Jul 2016.